Amgen’s new asthma treatment gets FDA approval
IN THIS ARTICLE
- Banking & Finance Topic
- Jorge Mercado Author
By Jorge Mercado Wednesday, December 22nd, 2021
In the mid-2000s, Jane Parnes was living happily in the Bay Area, a tenured and well-respected professor at Stanford University with two kids, the oldest about to begin high school. But while on leave from Stanford in 2006, Parnes found herself at Amgen, and a couple months later found herself there permanently, working on a…